Author Correction: Invest New Drugs (2019) 37(6):1177–1186. https://doi.org/10.1007/s10637-019-00748-w

We noted two image misalignments in Figs. 5a and 6b of the published version. These misalignments were copy and paste errors during image processing. Thus, we have accordingly corrected and replaced them. The conclusions of the paper remain unchanged.

Fig. 5
figure 1

Knockdown of DKC1 inhibits glioma cell migration. a Representative pictures of migration in U87 and U251 cells with DKC1 knockdown and controls

Full size image
Fig. 6
figure 2

Silencing of DKC1 alters the related signaling molecules in U251 and U87 cells. a, b Western blot analysis of the relative protein levels of N-cadherin, MMP-2, Cyclin E2, CDK2, HIF-1α in DKC1 knockdown, and control groups of U251 and U87 cells. GAPDH was used as a reference control

Full size image